Cresco Labs Inc.
CL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 178.46M | 181.18M | 181.71M | 185.01M | 186.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 178.46M | 181.18M | 181.71M | 185.01M | 186.93M |
| Cost of Revenue | 86.35M | 89.58M | 92.08M | 92.09M | 96.92M |
| Gross Profit | 92.11M | 91.60M | 89.62M | 92.92M | 90.01M |
| SG&A Expenses | 57.75M | 53.51M | 54.56M | 55.82M | 62.33M |
| Depreciation & Amortization | 5.70M | 5.19M | 5.42M | 9.98M | 5.94M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 149.79M | 148.28M | 152.06M | 157.89M | 165.19M |
| Operating Income | 28.66M | 32.90M | 29.65M | 27.12M | 21.74M |
| Income Before Tax | 11.32M | -40.94M | 15.95M | 12.82M | -119.19M |
| Income Tax Expenses | 19.02M | 10.24M | 18.00M | 7.95M | -5.75M |
| Earnings from Continuing Operations | -7.69M | -51.18M | -2.06M | 4.87M | -113.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.85M | -3.15M | -3.14M | -2.23M | -2.13M |
| Net Income | -10.54M | -54.33M | -5.19M | 2.64M | -115.57M |
| EBIT | 28.66M | 32.90M | 29.65M | 27.12M | 21.74M |
| EBITDA | 43.59M | 47.83M | 44.98M | 47.38M | 37.03M |
| EPS Basic | -0.03 | -0.16 | -0.02 | 0.01 | -0.34 |
| Normalized Basic EPS | 0.02 | -0.08 | 0.02 | 0.02 | 0.01 |
| EPS Diluted | -0.03 | -0.16 | -0.02 | 0.01 | -0.34 |
| Normalized Diluted EPS | 0.02 | -0.08 | 0.02 | 0.02 | 0.01 |
| Average Basic Shares Outstanding | 347.36M | 344.93M | 341.63M | 339.12M | 337.47M |
| Average Diluted Shares Outstanding | 347.36M | 344.93M | 341.63M | 339.12M | 337.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.90% | -- | -- | -- | -- |
